Responses
Unexpected outcome (positive or negative) including adverse drug reactions
Spironolactone, a possible selective androgen receptor modulator, should be used with caution in patients with metastatic carcinoma of the prostate
Compose a Response to This Article
Other responses
No responses have been published for this article.